Business
Vortex and STRATEC Announce Global Partnership
Vortex and STRATEC Announce Global Partnership.
About this update from Emv Capital Plc
[{"type":"text","content":"\n \nRNS Number : 9249F NetScientific PLC 01 November 2018 \n\n \n \n \n \nNetScientific plc\n(\"NetScientific\" or the \"Company\" or the \"Group\")\n \n \nVortex Biosciences and STRATEC GmbH announce global partnership to scale-up manufacturing for liquid biopsy platform\n \nLondon, UK - 1 November 2018 - NetScientific plc (\"NetScientific\", AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that its US-based portfolio company, Vortex BioSciences, has entered into a global manufacturing agreement with STRATEC Consumables GmbH (\"STRATEC\") to produce a customised chip, a crucial component of Vortex's automated liquid biopsy platform (VTX-1). STRATEC will also assist Vortex with scale-up to commercialisation with a view to increasing the product's prominence in the clinical space as a diagnostic and monitoring tool.\n \nCommenting on the news, Francois Martelet, Chairman of Vortex BioSciences Inc. and CEO of NetScientific said: \"Partnering with STRATEC to manufacture the VTX-1 microfluidic chip will create a reproducible process that will allow Vortex's technology to enter the market and readily address demand as it surges. We look forward to the results of this collaboration and foresee Vortex playing a crucial role in establishing CTCs as part of the standard of care in oncology treatment.\"\n \nNetScientific holds 66.1% of Vortex Biosciences on a fully diluted basis.\n \n# # #\n \nFor more information, please contact:\n \n\n\n\n NetScientific\n François R. Martelet, M.D., CEO\n Ian Postlethwaite, CFO\n\n\nTel: +44 (0)20 3514 1800\n\n\n\n\n \n Consilium Strategic Communications\n Mary-Jane Elliott / Chris Welsh / \n Laura Thornton \n\n\n \nTel: +44 (0)20 3709 5700\[email protected]\n\n\n\n\nWHIreland (NOMAD and Broker)\nChris Fielding / Jessica Cave /\nChris Viggor\n \nVortex Biosciences \nBob Englert, CEO\n\n\n \nTel: +44 (0)20 7220 1666\n \[email protected]\n\n\n\n \n \nAbout NetScientific \n \nNetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people wi...